Icon Plc
Market Cap
11B
Short interest (May 15)
4.3%
Net Short (Jun 03 ): 0.2%
Borrow Fee
0.40%
↑ 19.1%
Available Shares
500K
↓ 15.7%
Price Chart
Company Overview
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.